Sharon M. Watling
Plus aucun poste en cours
Profil
Sharon M.
Watling worked as a Senior Director of Clinical Development at Metabasis Therapeutics, Inc. and as a Vice President of Clinical and Regulatory at Vericel Corp.
She holds a doctorate degree from the University of Michigan.
Anciens postes connus de Sharon M. Watling
| Sociétés | Poste | Fin |
|---|---|---|
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Directeur Technique/Scientifique/R&D | - |
| VERICEL CORPORATION | Directeur Technique/Scientifique/R&D | - |
Formation de Sharon M. Watling
| University of Michigan | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
